Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...

Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over ...

Rival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial over life ... American competitor Pfizer and its German-partner BioNTech for alleged patent ...

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...

GSK (GSK) is reportedly suing Pfizer (PFE) and partner BioNTech (BNTX) for patent infringement over the use of certain mRNA ...

Representatives for Pfizer ... Trial and Appeal Board, which reconsiders the validity of patents issued by the office, as an alternative path to fend off infringement claims. Pfizer and BioNTech ...

Pfizer and BioNTech have denied infringement with both firms seeking the 'revocation' of two Moderna patents, claiming that they are 'invalid'. An expected three-and-a-half week trial before judge ...

Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a ...

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the ...

The lawsuit adds to a web of high-stakes U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their vaccines, including a case brought by Moderna ...

GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the ...